Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rainer Weber

Showing results (81-90 of 252) with videos related to

Pageof 26
Sort By:
The Journal of Antimicrobial Chemotherapy|July 12, 2008
Correlation between case mix index and antibiotic use in hospitalsStefan P Kuster, Christian Ruef, Alfred K Bollinger, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 23, 2011
Longer term clinical and virological outcome of sub-Saharan African participants on antiretroviral treatment in the Swiss HIV Cohort StudyCornelia Staehelin, Olivia Keiser, Alexandra Calmy, et al.
Plos One|September 30, 2015
Progression of Liver Fibrosis in HIV/HCV Co-Infection: A Comparison between Non-Invasive Assessment Methods and Liver BiopsyPatrick Schmid, Andrea Bregenzer, Milo Huber, et al.
AIDS (London, England)|January 25, 2003
HIV RNA in plasma rebounds within days during structured treatment interruptionsMarek Fischer, Roland Hafner, Christine Schneider, et al.
AIDS (London, England)|January 6, 2011
Interruptions of cART limits CD4 T-cell recovery and increases the risk for opportunistic complications and deathGilbert R Kaufmann, Luigia Elzi, Rainer Weber, et al.
HIV Clinical Trials|September 3, 2009
Discontinuation of enfuvirtide in heavily pretreated HIV-infected individualsLuigia Elzi, Gilbert Kaufmann, Rainer Weber, et al.
Journal of Medical Virology|July 19, 2006
HIV replication elicits little cytopathic effects in vivo: analysis of surrogate markers for virus production, cytotoxic T cell response and infected cell deathGeorg A Funk, Annette Oxenius, Marek Fischer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 8, 2017
Hepatitis C Infection and the Risk of Non-Liver-Related Morbidity and Mortality in HIV-Infected Persons in the Swiss HIV Cohort StudyHelen Kovari, Andri Rauch, Roger Kouyos, et al.
The Journal of Infectious Diseases|June 16, 2007
Positive in vivo selection of the HIV-1 envelope protein gp120 occurs at surface-exposed regionsBeda Joos, Marek Fischer, Andreas Schweizer, et al.
Therapeutische Umschau. Revue Therapeutique|August 6, 2014
[Antiretroviral therapy]Amrei von Braun, Hansjakob Furrer, Manuel Battegay, et al.
Pageof 26

Showing results (81-90 of 252) with videos related to

Sort By:
Pageof 26
The Journal of Antimicrobial Chemotherapy|July 12, 2008
Correlation between case mix index and antibiotic use in hospitalsStefan P Kuster, Christian Ruef, Alfred K Bollinger, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 23, 2011
Longer term clinical and virological outcome of sub-Saharan African participants on antiretroviral treatment in the Swiss HIV Cohort StudyCornelia Staehelin, Olivia Keiser, Alexandra Calmy, et al.
Plos One|September 30, 2015
Progression of Liver Fibrosis in HIV/HCV Co-Infection: A Comparison between Non-Invasive Assessment Methods and Liver BiopsyPatrick Schmid, Andrea Bregenzer, Milo Huber, et al.
AIDS (London, England)|January 25, 2003
HIV RNA in plasma rebounds within days during structured treatment interruptionsMarek Fischer, Roland Hafner, Christine Schneider, et al.
AIDS (London, England)|January 6, 2011
Interruptions of cART limits CD4 T-cell recovery and increases the risk for opportunistic complications and deathGilbert R Kaufmann, Luigia Elzi, Rainer Weber, et al.
HIV Clinical Trials|September 3, 2009
Discontinuation of enfuvirtide in heavily pretreated HIV-infected individualsLuigia Elzi, Gilbert Kaufmann, Rainer Weber, et al.
Journal of Medical Virology|July 19, 2006
HIV replication elicits little cytopathic effects in vivo: analysis of surrogate markers for virus production, cytotoxic T cell response and infected cell deathGeorg A Funk, Annette Oxenius, Marek Fischer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 8, 2017
Hepatitis C Infection and the Risk of Non-Liver-Related Morbidity and Mortality in HIV-Infected Persons in the Swiss HIV Cohort StudyHelen Kovari, Andri Rauch, Roger Kouyos, et al.
The Journal of Infectious Diseases|June 16, 2007
Positive in vivo selection of the HIV-1 envelope protein gp120 occurs at surface-exposed regionsBeda Joos, Marek Fischer, Andreas Schweizer, et al.
Therapeutische Umschau. Revue Therapeutique|August 6, 2014
[Antiretroviral therapy]Amrei von Braun, Hansjakob Furrer, Manuel Battegay, et al.
Pageof 26